Rapid blood test to detect severe disease risk of Covid-19 patients

Researchers have shown that a relatively simple and rapid blood test could predict which patients with Covid-19 are at highest risk of severe complications or death

blood test
File photo of a patient getting blood test. Photo: Shutterstock
IANS New York
2 min read Last Updated : Jan 16 2021 | 7:18 PM IST

Researchers, including one of Indian origin, have shown that a relatively simple and rapid blood test could predict -- within a day of a hospital admission -- which patients with Covid-19 are at highest risk of severe complications or death.

The study published in the JCI Insight journal indicates that the blood test measures levels of mitochondrial DNA, a unique type of DNA molecule that normally resides inside the energy factories of cells.

Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

"We will need larger trials to verify what we found in this study, but if we could determine in the first 24 hours of admission whether a patient is likely to need dialysis/incubation or medication to keep their blood pressure from dropping too low, that would change how we triage the patient and it might change how we manage them much earlier in the course of the disease," said researcher Hrishikesh S. Kulkarni, Assistant Professor at the Washington University in the US.

The test could serve as a way to predict disease severity as well as a tool to better design clinical trials, identifying patients who might benefit from specific investigational treatments.

The team evaluated 97 patients with Covid-19, measuring their mitochondrial DNA levels on the first day of their hospital stay.

They found that mitochondrial DNA levels were much higher in patients who eventually were admitted to the ICU, incubated or died. The researchers found this association held independently of a patient's age, sex and underlying health conditions.

On an average, mitochondrial DNA levels were nearly tenfold higher in patients with Covid-19 who developed severe lung dysfunction or eventually died.

Those with elevated levels were nearly six times more likely to be incubated, three times more likely to be admitted to the ICU and nearly twice as likely to die compared with those with lower levels.

--IANS

vc/khz/bg

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

First Published: Jan 16 2021 | 7:15 PM IST

Next Story